<DOC>
	<DOCNO>NCT02546310</DOCNO>
	<brief_summary>To determine treatment HTL0009936 lead change neural activity , measure use fMRI BOLD signal ASL , brain area associate spatial work memory , learn executive functioning .</brief_summary>
	<brief_title>Phase 1 Study Investigating Effects HTL0009936 Cognition BOLD fMRI Signals Healthy Elderly Subjects</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Healthy basis medical history , physical examination , vital sign , 12lead ECG , haematology , blood chemistry , urinalysis prestudy psychological assessment . Mini Mental State Examination ( MMSE ) Score â‰¥24 . Intermediate extensive metaboliser determine CYP2D6 genotype . Fluent English speaker . Righthanded . Not regular smoker Recreational drug use within 3 month prior Screening Visit . Positive alcohol breath test . Positive urine drug screen . Consumption large amount caffeinated drink . Consumption food drink contain cranberry , pomegranate , star fruit , grapefruit , pomelo , exotic citrus fruit Seville orange . Ultrarapid poor metabolizer determine CYP2D6 genotype . By selfreport , take two daytime nap per week opinion investigator likely interfere ability subject complete study procedure . History , present ( opinion Investigator ) , significant neurological psychiatric condition . Personal family history congenital long QT syndrome sudden death . Concomitant use drug metabolise and/or inhibitor CYP2D6 . Concomitant use drug substrates organic cation transporter 2 . History significant claustrophobia . Fulfils MRI contraindication standard site radiography screen questionnaire ( e.g . history surgery involve metal implant ) .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>